Atrasentan in Treating Patients With Prostate Cancer

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase III trial to determine the effectiveness of atrasentan in treating patients who have prostate cancer that has not responded to hormone therapy.

Timeline

Start

2002-09

Primary completion

2007-06

Completion

—

Drugs

Indications